Final Results of a Phase III Clinical Trial on Adjuvant Intraportal Infusion with Heparin and 5-Fluorouracil (5-FU) in Resectable Colon Cancer (EORTC GITCCG 1983-1987)

Author： Nitti D.   Wils J.   Sahmoud T.   Curran D.   Couvreur M.L.   Lise M.   Rauschecker H.   Guimaraes dos Santos J.   Stremmel W.   Roelofsen F.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.8, 1997-07, pp. : 1209-1215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results of a Phase II Trial of Epirubicin and Cisplatin (EP) Before and After Irradiation and 5-Fluorouracil in Locally Advanced Pancreatic Cancer: An EORTC GITCCG Study

By Wagener D.J.T.   Hoogenraad W.J.   Rougier P.   Lusinchi A.   Taal B.G.   Veenhof C.H.N.   de Graeff A.   Conroy T.   Curran D.   Sahmoud T.   Wils J.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1310-1313

Elsevier

Access to resources Recommend Favorite

5-Fluorouracil (5-FU) Continuous Intravenous Infusion Compared with Bolus Administration. Final Results of a Randomised Trial in Metastatic Colorectal Cancer

By Rougier P.   Paillot B.   LaPlanche A.   Morvan F.   Seitz J.F.   Rekacewicz C.   Laplaige P.   Jacob J.   Grandjouan S.   Tigaud J.M.   Fabri M.C.   Luboinski M.   Ducreux M.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1789-1793

Elsevier

Access to resources Recommend Favorite

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

By Dahl Olav   Fluge Øystein   Carlsen Erik   Wiig Johan   Myrvold Helge   Vonen Barthold   Podhorny Nina   Bjerkeset Ottar   Eide Tor Jack   Halvorsen Tore   Tveit Kjell Magne  

Acta Oncologica, Vol. 48, Iss. 3, 2009-04 ,pp. : 368-376

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer

By Hütter G.   Szélenyi H.   Deckert P.   Keilholz U.   Thiel E.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 178-184

Springer Publishing Company

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite